Metabolomic study of serum from rabbits with acute acalculous cholecystitis

Inflammation Research

Volumn 61, Issue 9, 2012, Pages 987-995

  Li, Zhituo ^a   Shen, Huaishu ^a   Zhang, Yingmei ^a   Lu, Ming ^b   Qiao, Xin ^b   Meng, Xianzhi ^a   Sun, Bei ^a   Xue, Dongbo ^a   Zhang, Weihui ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acalculous cholecystitis; Inflammation; Metabolomics; Multivariate statistical analysis

Indexed keywords

3 HYDROXYBUTYRIC ACID; ASPARAGINE; CITRIC ACID; GLUCOSE; HISTIDINE; LACTIC ACID; LOW DENSITY LIPOPROTEIN; LYSINE; PHOSPHOLIPID; SODIUM CHLORIDE; VERY LOW DENSITY LIPOPROTEIN;

3 HYDROXYBUTYRIC ACID BLOOD LEVEL; ACALCULOUS CHOLECYSTITIS; ACUTE CHOLECYSTITIS; AMINO ACID BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARAGINE BLOOD LEVEL; BLOOD LEVEL; CITRIC ACID BLOOD LEVEL; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GLUCOSE BLOOD LEVEL; HISTIDINE BLOOD LEVEL; HISTOPATHOLOGY; LACTATE BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LOW DENSITY LIPOPROTEIN BLOOD LEVEL; LYSINE BLOOD LEVEL; METABOLITE; METABOLOMICS; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; PROTON NUCLEAR MAGNETIC RESONANCE; VERY LOW DENSITY LIPOPROTEIN BLOOD LEVEL;

ACALCULOUS CHOLECYSTITIS; ANIMALS; CHOLECYSTITIS, ACUTE; FEMALE; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOMICS; RABBITS;

EID: 84865146890     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-012-0491-1     Document Type: Article

References (30)

1. Barie PS, Eachempati SR. Acute acalculous cholecystitis. Gastroenterol Clin North Am. 2010;39:343-57.
2. Johnson LB. The importance of early diagnosis of acute acalculous cholecystitis. Surg Gynecol Obstet. 1987;164:197-203. (Pubitemid 17048586)
3. Kallifas S, Ziegler DW, Flancbaum L, Choban PS. Acute acalculous cholecystitis: incidence, risk factors, diagnosis and outcome. Am Surg. 1998;64:471-5. (Pubitemid 28208797)
4. McChesney JA, Northup PG, Bickston SJ. Acute acalculous cholecystitis associated with systemic sepsis and visceral arterial hypoperfusion: a case series and review of pathophysiology. Dig Dis Sci. 2003;48:1960-7. (Pubitemid 37410084)
5. Barie PS, Fischer E. Acute acalculous cholecystitis. J Am Coll Surg. 1995;180:232-44.
6. Kamimura T, Mimori A, Takeda A, Masuyama J, Yoshio T, Okazaki H, et al. Acute acalculous cholecystitis in systemic lupus erythematous: a case report and review of the literature. Lupus. 1998;7:361-3. (Pubitemid 28347017)
7. Jannuzzi C, Belghiti J, Erlinger S, Menu Y, Fekete F. Cholangitis associated with cholecystitis in patients with acquired immunodeficiency syndrome. Arch Surg. 1990;125:1211-3. (Pubitemid 20283117)
8. Sinclair AJ, Viant MR, Ball AK, Burdon MA, Walker EA, Stewart PM, et al. NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases-a diagnostic tool? NMR Biomed. 2010;23:123-32.
9. Sitter B, Bathen TF, Singstad TE, Fjøsne HE, Lundgren S, Halgunset J, et al. Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy. NMR Biomed. 2010;23:424-31.
10. Monleón D, Morales JM, Barrasa A, López JA, Vázquez C, Celda B. Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed. 2009;22:342-8.
11. Pan Z, Raftery D. Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Anal Bioanal Chem. 2007;387:525-7. (Pubitemid 46067468)
12. Abedin MZ, Narins SC, Park EH. Lovastatin alters biliary lipid composition and dissolves gallstones: a long-term study in prairie dogs. Dig Dis Sci. 2002;47:2192-210. (Pubitemid 35205294)
13. Shebl FM, Andreotti G, Rashid A, Gao YT, Yu K, Shen MC, et al. Serum lipid levels and the risk of biliary tract cancers and biliary stones: a population-based study in China. Int J Cancer. 2008;122:2322-9. (Pubitemid 351542338)
14. Paumgartner G. Biliary physiology and disease: reflections of a physician-scientist. Hepatology. 2010;51:1095-106.
15. Portincasa P, Di Ciaula A, vanBerge-Henegouwen GP. Smooth muscle function and dysfunction in gallbladder disease. Curr Gastroenterol Rep. 2004;6:151-62. (Pubitemid 38915062)
16. Tsai CJ. Steatocholecystitis and fatty gallbladder disease. Dig Dis Sci. 2009;54:1857-63.
17. Davis SC, Clark S, Hayes JR, Green TL, Gruetter CA. Up-regulation of histidine decarboxylase expression and histamine content in B16F10 murine melanoma cells. Inflamm Res. 2011;60:55-61.
18. Szukiewicz D, Szewczyk G, Mittal TK, Rongies W, Maslinski S. Involvement of histamine and histamine H2 receptors in nicotinamide- induced differentiation of human amniotic epithelial cells into insulin-producing cells. Inflamm Res. 2010;59
19. (Suppl 2):S209-11.
20. Clejan S, Japa S, Clemetson C, Hasabnis SS, David O, Talano JV. Blood histamine is associated with coronary artery disease, cardiac events and severity of inflammation and atherosclerosis. J Cell Mol Med. 2002;6:583-92. (Pubitemid 44146436)
21. Jutel M, Watanabe T, Klunker S, Akdis M, Thomet OA, Malolepszy J, et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature. 2001;413:420-5. (Pubitemid 32928596)
22. Lethbridge NL, Chazot PL. Immunological identification of the mouse H4 histamine receptor on spinal cord motor neurons using a novel anti-mouse H4R antibody. Inflamm Res. 2010;59: S197-8.
23. Nies C, Krack W, Lorenz W, Kaufmann T, Sitter H, Celik I, Rothmund M. Histamine release in conventional versus minimally invasive surgery: results of a randomised trial in acute cholecystitis. Inflamm Res. 1997;46:S83-4.
24. Clanachan AS, Courtney DF, Scott GW. Stimulatory and inhibitory histamine receptors in canine cystic duct. Br J Pharmacol. 1982;77:717-23. (Pubitemid 13250619)
25. Schuch R, Fischetti VA, Nelson DC. A genetic screen to identify bacteriophage lysins. Methods Mol Biol. 2009;502:307-19.
26. Maurer KJ, Carey MC, Fox JG. Roles of infection, inflammation, and the immune system in cholesterol gallstone formation. Gastroenterology. 2009;136:425-40.
27. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860-7. (Pubitemid 46024993)
28. Rusconi B, Greub G. Chlamydiales and the innate immune response: friend or foe? FEMS Immunol Med Microbiol. 2011; 61:231-44.
29. Dhabhar FS. Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection versus immunopathology. Allergy Asthma Clin Immunol. 2008;4:2-11. (Pubitemid 351729462)
30. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111-9. (Pubitemid 40629025)